MedPath

Comparison of platelet rich plasma and triamcinolone in patient of osteoarthritis of knee for pain relief.

Not yet recruiting
Conditions
Osteoarthritis of knee, unspecified, (2) ICD-10 Condition: M179||Osteoarthritis of knee, unspecified, (3) ICD-10 Condition: M171||Unilateral primary osteoarthritisof knee, (4) ICD-10 Condition: M171||Unilateral primary osteoarthritisof knee,
Registration Number
CTRI/2022/04/042058
Lead Sponsor
Government medical college bhavnagr
Brief Summary

After taking approval from ethic committee,study will be initiated on patient fulfilling inclusion criteria ,pt will be assessed for pain decrement by VAS Score ,function and  mobility increment and generic healthimprovement  by  KOOS score (Kneeinjury and OA Outcome) (at 6 week)&prevention and  slowing of the progress of disease  by KELLGREN & LAWRENCE Grade  (at 3 months ) between two group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

1)Grades I , II, III Knee OA according to criteria of American college of rheumatology 2)History of chronic pain > 3 month duration 3)Swelling of knee > 4 month 4)X-ray diagnosis ( Kellgren Lawrence 1 and 2).

Exclusion Criteria

1)Knee joint deformities 2)Acute infection 3)H/o knee surgery 4)H/o diabetes mellitus 5)H/o rheumatoid arthritis, gout H/o severe cardio vascular disorder, 5)haematological disorders, renal disorder Immunodeficiency 6)Patients taking anticoagulants 7)Patients with haemoglobin values of <10 and platelets values of <1,50,000/mm3 8)H/o vasovagal shock 9)Pregnant and lactating females 10)H/o corticosteroid consumption within last 3 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)To compare pain decrement by VAS Score ( Visual analogue score).1)To compare pain decrement by VAS Score ( Visual analogue score). | T2)o compare function and mobility increment and generic health improvement by KOOS score (Knee injury and OA Outcome)(at 6 week) | 3)To compare prevention and slowing of the progress of disease by KELLGREN & LAWRENCE Grade (at 3 months ) between two group.
T2)o compare function and mobility increment and generic health improvement by KOOS score (Knee injury and OA Outcome)(at 6 week)1)To compare pain decrement by VAS Score ( Visual analogue score). | T2)o compare function and mobility increment and generic health improvement by KOOS score (Knee injury and OA Outcome)(at 6 week) | 3)To compare prevention and slowing of the progress of disease by KELLGREN & LAWRENCE Grade (at 3 months ) between two group.
3)To compare prevention and slowing of the progress of disease by KELLGREN &amp; LAWRENCE Grade (at 3 months ) between two group.1)To compare pain decrement by VAS Score ( Visual analogue score). | T2)o compare function and mobility increment and generic health improvement by KOOS score (Knee injury and OA Outcome)(at 6 week) | 3)To compare prevention and slowing of the progress of disease by KELLGREN & LAWRENCE Grade (at 3 months ) between two group.
Secondary Outcome Measures
NameTimeMethod
1)To compare analgesic requirement during the study period between two group.2)To compare need of surgical intervention require during study period Between two group.

Trial Locations

Locations (1)

Government medical college bhavnagar

🇮🇳

Bhavnagar, GUJARAT, India

Government medical college bhavnagar
🇮🇳Bhavnagar, GUJARAT, India
Jankiben Panchal
Principal investigator
6354517097
panchaljanki222@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.